Historic Events

Beximco Pharmaceuticals Ltd. commenced export of medicine to Kuwait

Beximco Pharmaceuticals Ltd. commenced export of medicine to Kuwait on 16th June, 2016. This is the first time a Bangladeshi pharma company has launched pharmaceutical products in any gulf member country (GCC).

Launching ceremony was held at the factory premises of Beximco Pharma to mark the shipment of first consignment to Kuwait in presence of the Ambassador of Kuwait, His Excellency Mr. Mohammad A.H. Hayat. Vice Chairman of Beximco group Mr. Salman F. Rahman, Beximco Pharma′s Managing Director Mr. Nazmul Hassan, MP, Chief Operating Officer Mr. Rabbur Reza and other high officials of the company were also present on this occasion. The Ambassador has also seen the operations of various units at Tongi factory and expressed high satisfaction over the state-of-the-art facilities and quality control practices of Beximco Pharma.

Initially two metered dose inhaler products for asthma and respiratory disorder namely Azmasol (Salbutamol) and Bexitrol-F (Salbutamol plus Fluticasone) and one blood pressure drug Amdocal (Amlodipine) are being exported to Kuwait.

 

News Feed

First time a Bangladeshi pharmaceutical company has launched pharmaceutical products in any gulf member country.
Beximco Pharmaceuticals Limited (“BPL”, “Beximco Pharma” or “Company”), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces that it has commenced the export of pharmaceuticals to Kuwait. This marks the first time a Bangladeshi pharmaceutical company has launched pharmaceutical products in any Gulf member country under the Gulf Cooperation Council (GCC).

Read more...

Beximco Pharmaceuticals Limited (BPL), a leading medicine manufacturers and exporters in the country, has started exporting pharmacy products to Kuwait. This is the first time a Bangladeshi pharmaceutical company has dispatched pharmaceutical products to a member country of Gulp Cooperative Council (GCC). The shipment of the first consignment to Kuwait was inaugurated at a ceremony held at the factory premises of Beximco Pharma at Tongi on Thursday.

Read more...

Beximco Pharmaceuticals Ltd (BPL), a fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, entered the Kuwaiti pharma market yesterday. It did so by launching two inhalers for respiratory disorders and a blood pressure drug.

Read more...

Beximco Pharmaceuticals Limited is set to start exporting medicines to Kuwait for the first time amongst the local pharmaceuticals companies, officials said. The pharmaceutical market of Kuwait is one of the most potential markets among the Gulf Cooperation Council (GCC). Total pharma market of GCC, which consists of six nations, is currently valued at around US$ 9.0 billion and the pharma market of Kuwait is about $ 1.0 billion.

Read more...

Beximco Pharmaceuticals, the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has commenced the export of pharmaceuticals to Kuwait. This marks the first time a Bangladeshi pharmaceutical company has launched drug products in any Gulf member country under the Gulf Co-Operation Council (GCC).

Read more...

Beximco Pharmaceuticals Limited is mulling to export $1 billion dollar worth of medicine within next five years, which was $15 million last year. Beximco Pharma had worked hard for the last seven years to get necessary approvals from the authorities which are normally a lengthy process as well. Salman F Rahman, Vice Chairman of the Beximco Group said this while replying to a question from the journalists during the inauguration of export of medicine to Kuwait.

Read more...